What Researchers Did
Researchers conducted a double-blind, randomized controlled trial to assess the efficacy and safety of hyperbaric oxygenation therapy for preserving erectile function after robot-assisted radical prostatectomy.
What They Found
Of 109 potent men randomized, 43 in the control group and 40 in the hyperbaric oxygenation therapy group completed 18-month follow-up. The study found no statistically significant differences in erectile function at 18 months, as measured by the IIEF, or in any secondary outcomes between the two groups.
What This Means for Canadian Patients
Canadian patients undergoing radical prostatectomy for prostate cancer should be aware that hyperbaric oxygenation therapy did not demonstrate a benefit in preserving erectile function in this study. Therefore, this specific therapy may not be a recommended option for penile rehabilitation based on these findings.
Canadian Relevance
This study has no direct Canadian connection as it was not conducted in Canada or by Canadian researchers.
Study Limitations
A potential limitation is the number of participants who completed the full 18-month follow-up, which could impact the study's power to detect subtle differences.